CyberKnife treatment for elderly patients with oral cancer

Abstract

CyberKnife （CK） treatment for elderly patients with oral cancer （75 or older） was analyzed. The subjects were 26 patients （10 males and 16 females; age range 75-98, median 84）, who were followed up for more than one year. The range of tumor volume was 3.5-223.3ml （median 47.4ml）, which were treated with 21.0-35.0 Gy by 3-7 fractions. Median overall survival and progression-free survival after CK treatment were 24 months and 12 months, respectively. CK treatment appears to be feasible for elderly patients with oral cancer.